NIH-funded research R01 grant

How DNA packaging controls cell identity

Official title: Role of nucleosome architecture in cellular reprogramming

Funded at University of North Dakota · NIH-11164506 · Data updated 2026-11-12

Researchers are looking at how the way DNA is packaged lets certain proteins unlock genes to change a cell's identity, which could one day help people with diseases such as cancer.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of North Dakota
NIH-funded
Lab location1 site (Grand Forks, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2028
Funding year2025
Award (this year)$296,100
NIH project number5R01GM148729-03
Project IDNIH-11164506 on NIH RePORTER

Who could benefit from this research

Could help

This grant funds lab-based research and is not recruiting patients now; future studies stemming from this work might involve people with cancers linked to these gene-regulation errors.

Less likely to help

People looking for an immediate treatment or those with conditions unrelated to gene regulation are unlikely to benefit from this research in the short term.

What this research studies

This project studies proteins called pioneer factors that can bind to DNA wrapped around nucleosomes and open up otherwise closed regions of the genome. Scientists use lab-grown cells and molecular tools to map where these factors bind and how they change chromatin structure. They will manipulate these factors and nucleosome architecture in controlled experiments to see which changes are needed to turn genes on or off. Because misregulation of these processes is linked to cancers, understanding the mechanisms could point to future diagnostic markers or therapies.

Why it matters

Potential benefit: If successful, this work could identify new ways to reprogram cells or new targets for treating cancers caused by errors in gene regulation.

How similar studies have gone: Previous lab studies have shown pioneer factors can open chromatin in cells, but translating these basic findings into clinical treatments is still at an early and unproven stage.

Where this research is happening

  • University of North Dakota
    Grand Forks, United States
    Active

Researchers

  • Principal investigator: Takaku, Motoki — University of North Dakota
  • Study coordinator: Takaku, Motoki

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.